Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observational study of adherence to telaprevir-based therapy in chronic hepatitis C genotype 1
NL-OMON39839Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of telaprevir in hepatitis C virus infection, sponsored by Amsterdam University Medical Center. Primary endpoint: Mean adherence to telaprevir. Started May 2013; status: active, not recruiting.
02
Drugs
telaprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NL-OMON39839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39839.